JUUL Lawsuit Settlement Nets Millions for Schools

Mar.22.2023
JUUL Lawsuit Settlement Nets Millions for Schools
Florida school board approves multi-million dollar settlement from JUUL lawsuit.

On March 21st, according to a report by Fox 13 News, Hillsborough County School Board members in Florida are expected to approve a settlement agreement with JUUL that will include compensation for the school. The funds, which are projected to reach millions of dollars and will be paid over the course of several years, are expected to be approved on Tuesday.


A settlement of $440 million.


In September 2022, the Attorney General of Connecticut announced that JUUL has agreed to pay nearly $440 million to settle over 30 lawsuits from several states concerning their high-nicotine electronic cigarette products. Following this, over 1300 school districts in the United States are currently learning about the settlement amounts they will receive.


To participate in a lawsuit claim, a school district must fulfill two requirements: the school must agree to divide 25% of the compensation with participating lawyers, and the school must provide information about the impact of e-cigarettes in their region.


A series of lawsuits has accused JUUL of using deceptive marketing strategies that target young people and harm their health with nicotine-infused e-cigarettes. The accusations also include school administrators being burdened with financial, time, and resource costs as a result of dealing with student addiction.


Previously, Frederick Hyde, the mayor of Polk County, stated that when school administrators conducted random searches, the item they found most frequently was electronic cigarettes. "Faced with the well-known screening before entering the building, students threw away the most electronic cigarettes in the trash cans in front of the school.


It has been reported that in early March, another Florida-based public school, Orange County, learned that it would receive $5.4 million from the settlement. A member of the Orange County school board stated that they intend to use this money to buy electronic cigarette detectors to protect students. They also plan to offer counseling to students who use e-cigarettes.


JUUL still faces lawsuits to contend with.


Since 2019, JUUL has been maintaining a low profile. It has abandoned all American advertising and removed its fruit and candy flavored e-cigarettes from store shelves.


The FDA took action in June 2022 by issuing a marketing ban on all JUUL products sold in the United States.


Subsequently, JUUL questioned this ruling in court. Afterwards, the FDA conducted a scientific review of the company's technology once again.


According to exclusive information compiled by 2FIRSTS, JUUL has paid a total of $2.6376 billion (approximately 18.2 billion RMB) in settlement funds and is still facing nine independent lawsuits from other states. Additionally, the company is also facing hundreds of individual lawsuits brought forth by teenagers and others.


Related reading:


JUUL has paid $18.2 billion in settlements as part of its effort to resolve ongoing legal issues. This article lists the settlement amounts and conditions in various states.


The American brand Juul will pay $440 million to reach a settlement with various states.


A US district court has approved a $255 million settlement for a class-action lawsuit against Juul prior to the start of the trial.


E-cigarette company JUUL has paid out $1.7 billion in settlements, following lawsuits from 34 different US states.


References:


Hillsborough County schools may be awarded millions of dollars as a result of a lawsuit filed against JUUL.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Kuwait Tightens Tobacco and Nicotine Rules, Bans Under-21 Sales and Extends Public Smoking Restrictions to Vapes and Heated Tobacco
Kuwait Tightens Tobacco and Nicotine Rules, Bans Under-21 Sales and Extends Public Smoking Restrictions to Vapes and Heated Tobacco
Kuwait has issued a comprehensive new regulatory framework covering tobacco, e-cigarettes, heated tobacco and other nicotine products. Ministerial Decision No. 237 of 2026, signed by Health Minister Ahmad Al-Awadhi, will take effect on January 1, 2027. The rules prohibit sales to people under 21 and ban sales through websites, apps, social media and delivery services. E-cigarettes and heated tobacco products will also be treated as smoking in public and enclosed places where smoking is prohibited. Nicotine pouches and other oral nicotine products not registered as medicines are banned.
Regulations
Aug.17 by 2Firsts Perspectives
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27